Cscec Scimee Sci.&Tech. Co.,Ltd (SHE:300425)
China · Delayed Price · Currency is CNY 4.980
-0.040 (-0.80%)
Apr 30, 2026, 3:04 PM CST
SHE:300425 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,587 | 1,588 | 1,520 | 1,661 | 1,702 | 1,445 |
Other Revenue | - | - | 16.34 | 10.03 | 17.47 | 16.37 |
| 1,587 | 1,588 | 1,537 | 1,671 | 1,720 | 1,461 | |
Revenue Growth (YoY) | -1.63% | 3.34% | -8.06% | -2.80% | 17.66% | 17.66% |
Cost of Revenue | 1,206 | 1,201 | 1,068 | 1,071 | 1,141 | 928.79 |
Gross Profit | 381.51 | 387.05 | 468.34 | 600.09 | 578.2 | 532.67 |
Selling, General & Admin | 232.15 | 241.48 | 273.81 | 289.8 | 275.7 | 270.47 |
Research & Development | 49.74 | 50.21 | 50.47 | 58.53 | 51 | 51.43 |
Other Operating Expenses | 8.85 | 5.34 | 3.49 | 7.29 | 5.24 | 2.52 |
Operating Expenses | 290.74 | 297.04 | 387.33 | 388.16 | 381.73 | 330.72 |
Operating Income | 90.77 | 90.02 | 81.01 | 211.93 | 196.47 | 201.96 |
Interest Expense | - | - | -33.89 | -30.48 | -26.4 | -23.35 |
Interest & Investment Income | 5.82 | 5.82 | 3.53 | 9.55 | 6.59 | 5.85 |
Earnings From Equity Investments | -0.57 | - | - | - | - | - |
Currency Exchange Gain (Loss) | - | - | 0.12 | -0.07 | -0.38 | -0.03 |
Other Non Operating Income (Expenses) | -77.69 | -77.42 | 5.53 | -3.25 | 7.11 | 1.3 |
EBT Excluding Unusual Items | 18.33 | 18.42 | 56.31 | 187.68 | 183.39 | 185.73 |
Gain (Loss) on Sale of Investments | - | - | -0.18 | -0.58 | - | - |
Gain (Loss) on Sale of Assets | -0.6 | -0.65 | 33.11 | 2.11 | 6.83 | 0.64 |
Asset Writedown | -0.39 | -0.59 | -0.03 | -3.04 | 0 | 0.01 |
Other Unusual Items | - | - | 11.26 | 9.96 | 16.2 | 16.27 |
Pretax Income | 17.34 | 17.18 | 100.47 | 196.12 | 206.42 | 202.66 |
Income Tax Expense | -0.58 | 0.37 | 6.14 | 16.64 | 7.7 | 18.6 |
Earnings From Continuing Operations | 17.92 | 16.81 | 94.33 | 179.48 | 198.72 | 184.06 |
Minority Interest in Earnings | -3.01 | -4.39 | -6.13 | -12.03 | -7.1 | -3.72 |
Net Income | 14.92 | 12.42 | 88.2 | 167.45 | 191.62 | 180.35 |
Net Income to Common | 14.92 | 12.42 | 88.2 | 167.45 | 191.62 | 180.35 |
Net Income Growth | -81.98% | -85.92% | -47.33% | -12.62% | 6.25% | 6.45% |
Shares Outstanding (Basic) | 669 | 682 | 679 | 676 | 676 | 676 |
Shares Outstanding (Diluted) | 669 | 682 | 679 | 678 | 676 | 676 |
Shares Change (YoY) | -1.39% | 0.48% | 0.20% | 0.26% | 0.03% | -0.01% |
EPS (Basic) | 0.02 | 0.02 | 0.13 | 0.25 | 0.28 | 0.27 |
EPS (Diluted) | 0.02 | 0.02 | 0.13 | 0.25 | 0.28 | 0.27 |
EPS Growth | -81.72% | -85.99% | -47.43% | -12.84% | 6.22% | 6.46% |
Free Cash Flow | 143.84 | 114.81 | 40.49 | -62.39 | -171.34 | -66.06 |
Free Cash Flow Per Share | 0.21 | 0.17 | 0.06 | -0.09 | -0.25 | -0.10 |
Dividend Per Share | - | - | 0.026 | 0.050 | 0.057 | 0.055 |
Dividend Growth | - | - | -47.54% | -13.05% | 3.64% | 10.00% |
Gross Margin | 24.04% | 24.37% | 30.48% | 35.90% | 33.62% | 36.45% |
Operating Margin | 5.72% | 5.67% | 5.27% | 12.68% | 11.43% | 13.82% |
Profit Margin | 0.94% | 0.78% | 5.74% | 10.02% | 11.14% | 12.34% |
Free Cash Flow Margin | 9.06% | 7.23% | 2.63% | -3.73% | -9.96% | -4.52% |
EBITDA | 191.2 | 190.61 | 182.23 | 309.77 | 290.22 | 274.56 |
EBITDA Margin | 12.05% | 12.00% | 11.86% | 18.53% | 16.88% | 18.79% |
D&A For EBITDA | 100.43 | 100.59 | 101.21 | 97.84 | 93.75 | 72.6 |
EBIT | 90.77 | 90.02 | 81.01 | 211.93 | 196.47 | 201.96 |
EBIT Margin | 5.72% | 5.67% | 5.27% | 12.68% | 11.43% | 13.82% |
Effective Tax Rate | - | 2.14% | 6.11% | 8.48% | 3.73% | 9.18% |
Revenue as Reported | - | - | 1,537 | 1,671 | 1,720 | 1,461 |
Advertising Expenses | - | - | 4.13 | 2.68 | 3.54 | 4.07 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.